February is the best month of the year to list your home for sale based on the likelihood of a seller successfully finding a buyer, according to research from Rightmove (RMV.L). The property platform's analysis, published on Wednesday, looked at millions of properties listed for sale between 2014 and 2024. However, it excluded 2020 from the analysis due to the pandemic, while 2025 was left out of the research to account for homes that were listed later in year and may still be on the market. From this analysis, Rightmove found that an average 68.9% of homes listed for sale in February went on to successfully find a buyer. January, when activity starts to ramp back up after the Christmas period, and March, which Rightmove noted to be the popular month in spring to sell, came in joint second place. An average 68.8% of homes which were listed for sale in those two months went onto find a buyer. The data suggested that April was the third best month to put a home up for sale, with 68.7% of properties listed going on to find a buyer, followed by May (67.7%). Rightmove pointed out spring is known for typically being the peak season for buying and selling. Given that it takes an average seven months to find a buyer and complete an onward purchase, Rightmove said that many people aim to make progress on moves in the spring, so they can try to be in a new home before Christmas. While October came in last place, the analysis showed that an average 65.4% of homes listed in this month still go onto find a buyer on average, which is not far behind February's rate. Rightmove said this highlighted that the "best time to come to market is when home-movers are ready and motivated". The property platform's analysis also found that January was the quickest month to find a buyer. The data showed that, over the 10-year period analysed, homes listed for sale in January found a buyer in an average of 47 days. February was found to be the second quickest month, at an average of 48 days. Ma...

Borregaard’s operating revenues increased to NOK 1,833 million (NOK 1,744 million)2 in the 4th quarter of 2025. EBITDA1 was NOK 405 million (NOK 398 million). The result in BioMaterials increased, while BioSolutions and Fine Chemicals had lower results compared with the 4th quarter of 2024. In BioSolutions, high deliveries of biovanillin and sustained growth in sales to agriculture were more than offset by increased costs. For BioMaterials, higher sales prices and lower wood and energy costs, more than compensated for other cost increases. For Fine Chemicals, lower bioethanol sales prices were partly offset by a strong result for fine chemical intermediates. Net currency effects were slightly positive for the Group. In the 4th quarter of 2025, Borregaard has made a total impairment of NOK 245 million of its investments in the bio-based start-ups Alginor ASA, Kaffe Bueno ApS and Lignovations GmbH to reflect recent development in these companies. The impairment is recorded as part of financial items. Profit before tax was NOK -28 million (NOK 170 million). Earnings per share were NOK -0.81 (NOK 1.30). Excluding impairments of bio-based start-ups, earnings per share were NOK 1.64. Full year 2025 Operating revenues increased to NOK 7,713 million (NOK 7,617 million) in 2025. EBITDA1 was NOK 1,878 million (NOK 1,874 million), an all-time high result. BioSolutions and BioMaterials had improved results, while Fine Chemicals had a decrease compared with 2024. Profit before tax was NOK 864 million (NOK 1,079 million). Earnings per share were NOK 6.22 (NOK 8.25). Excluding impairments of bio-based start-ups, earnings per share were NOK 8.67. - We are pleased to report another all‑time high EBITDA1 in 2025, driven by strong momentum across our business segments, despite the sharp decline in bioethanol prices and higher costs, says CEO Tom Erik Foss-Jacobsen. Contacts: Director Investor Relations, Pål Espen Ramberg, +47 959 17 333 Director Communications, Tone Horvei Bredal, +47...

Ad-hoc-Mitteilung gemäss Art. 53 KR Geschäftsjahr Der Nettoumsatz wuchs um +8% (kWk 1 , +8% USD), das operative Kernergebnis 1 verbesserte sich um +14% (kWk, +12% USD) Das Umsatzwachstum beruhte auf der weiterhin starken Performance der prioritären Marken wie Kisqali (+57% kWk), Kesimpta (+36% kWk), Pluvicto (+42% kWk), Scemblix (+85% kWk) und Cosentyx (+8% kWk) Die operative Kerngewinnmarge 1 erreichte 40,1%, +210 Basispunkte (kWk) Das operative Ergebnis verbesserte sich um +25% (kWk, +21% USD), der Reingewinn stieg um +19% (kWk, +17% USD) Der Kerngewinn pro Aktie 1 wuchs um +17% (kWk, +15% USD) auf USD 8,98 Der Free Cashflow1 belief sich infolge eines höheren Nettogeldflusses aus operativer Tätigkeit auf USD 17,6 Milliarden (+8% USD) Viertes Quartal Der Nettoumsatz ging aufgrund von Einbussen durch Generika und Anpassungen für Erlösminderungen in den USA um –1% (kWk, +1% USD) zurück; das operative Kernergebnis stieg um +1% (kWk, +1% USD) Die prioritären Marken behielten ihre starke Dynamik weiter bei, einschliesslich Kisqali (+44% kWk), Kesimpta (+27% kWk), Pluvicto (+70% kWk), Scemblix (+87% kWk) und Cosentyx (+11% kWk) Ausgewählte Meilensteine der Innovation im vierten Quartal: Zulassungsantrag für Remibrutinib beim häufigsten Subtyp chronisch induzierbarer Urtikaria (CINDU) bei der FDA eingereicht Positive Daten zu Pelabresib aus der Phase-III-Studie MANIFEST-2 nach 96 Wochen; Zulassungsantrag in der EU vorgesehen; Phase III in den USA geplant Zulassung der FDA für Itvisma als einzige Genersatztherapie für eine breite Patientenpopulation mit spinaler Muskelatrophie (SMA) Zulassung der Europäischen Kommission für Scemblix bei neu diagnostizierten Patienten mit Philadelphia-Chromosom-positiver chronischer myeloischer Leukämie (Ph+ CML) in der chronischen Phase Zulassungsantrag für Pluvicto bei PSMA-positivem metastasierendem hormonsensitivem Prostatakarzinom bei der FDA eingereicht Dividende, Prognose Für 2025 wird eine Dividende von CHF 3,70 pro Aktie – eine Erh...

Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +8% (cc 1 , +8% USD) with core operating income 1 up +14% (cc, +12% USD) Sales growth driven by continued strong performance from priority brands including Kisqali (+57% cc), Kesimpta (+36% cc), Pluvicto (+42% cc), Scemblix (+85% cc) and Cosentyx (+8% cc) Core operating income margin 1 was 40.1%, +210 basis points (cc) Operating income grew +25% (cc, +21% USD); net income up +19% (cc, +17% USD) Core EPS 1 grew +17% (cc, +15% USD) to USD 8.98 Free cash flow1 of USD 17.6 billion (+8% USD) driven by higher net cash flows from operating activities Fourth quarter Net sales -1% (cc, +1% USD), impacted by US generic erosion and revenue deduction adjustments; core operating income +1% (cc, +1% USD) Priority brands continued their strong momentum including Kisqali (+44% cc), Kesimpta (+27% cc), Pluvicto (+70% cc), Scemblix (+87% cc) and Cosentyx (+11% cc) Q4 selected innovation milestones: Remibrutinib FDA submission for the most common subtype of CINDU Pelabresib positive Phase III MANIFEST-2 96-week data; filing planned in EU, US Phase III planned Itvisma FDA approval as the only gene replacement therapy for a broad SMA population Scemblix EC approval for newly diagnosed patients with Ph+ CML in chronic phase Pluvicto FDA submission for PSMA+ metastatic hormone-sensitive prostate cancer Dividend, guidance Dividend of CHF 3.70 per share, an increase of 5.7% , proposed for 2025 , proposed for 2025 2026 guidance2 – Net sales expected to grow low single-digit and core operating income expected to decline low single-digit Basel, February 4, 2026 – Commenting on Q4 2025 results, Vas Narasimhan, CEO of Novartis, said: “Novartis delivered strong performance in 2025, with high single-digit sales growth and core margin expansion despite significant US generic entries. Growth drivers Kisqali, Kesimpta, Pluvicto, Scemblix and Cosentyx continued their strong trajectory. We advanced several potential multi-blockbusters ...

ACTIVITÉ DYNAMIQUE ET RÉSULTATS ÉLEVÉS EN 2025 CREDIT AGRICOLE S.A. GROUPE CREDIT AGRICOLE En m€ 2025 Var. 2025/2024 2025 Var.2025/2024 Revenus 28 079 +3,3% 39 558 +3,9% Charges -15 628 +4,9% -23 568 +3,7% Résultat Brut d’Exploitation 12 451 +1,3% 15 990 +4,3% Coût du risque -1 973 +6,6% -3 452 +8,2% RNPG 7 074 -0,2% 8 754 +1,3% COEX 55,7% +0,9 pp 59,6% -0,1 pp RÉSULTATS ANNUELS ÉLEVÉS Résultats annuels et rentabilité élevés (> 7Mds€ pour Crédit Agricole S.A., retour sur fonds propres tangibles de 13,5%), portés par des revenus annuels record qui permettent d’absorber la surtaxe IS (Groupe Crédit Agricole : 280 m€, Crédit Agricole S.A. : 147 m€) (> 7Mds€ pour Crédit Agricole S.A., retour sur fonds propres tangibles de 13,5%), portés par des (Groupe Crédit Agricole : 280 m€, Crédit Agricole S.A. : 147 m€) Résultats trimestriels impactés par l’effet de première consolidation de Banco BPM et r evenus trimestriels de haut niveau portés par une bonne performance de tous les métiers et marqué par le rebond de la banque de proximité en France et r portés par une bonne performance de tous les métiers et marqué par le rebond de la banque de proximité en France Coût du risque stable (Groupe Crédit Agricole : 28 points de base sur encours, Crédit Agricole S.A. : 35 points de base sur encours) DIVIDENDE 2025 PROPOSÉ EN HAUSSE À 1,13 € PAR ACTION (+3% VS. 2024) FORTE DYNAMIQUE DE CROISSANCE DANS TOUS LES MÉTIERS EN 2025 Production de crédit soutenue : en France, rebond sur l’habitat (+21%) et de la bonne dynamique auprès des entreprises ; activité soutenue à l’international ; production de haut niveau et équilibrée entre le personal finance et la mobilité en France, rebond sur l’habitat (+21%) et de la bonne dynamique auprès des entreprises ; activité soutenue à l’international ; production de haut niveau et équilibrée entre le et la mobilité Chiffre d’affaires et collecte nette annuels record en assurance, tiré par toutes les activités, et collecte nette de haut niveau en gesti...

DYNAMIC ACTIVITY AND STRONG RESULTS IN 2025 CRÉDIT AGRICOLE S.A. CRÉDIT AGRICOLE GROUP €m 2025 Var. 2025/2024 2025 Var. 2025/2024 Revenues 28,079 +3.3% 39,558 +3.9% Expenses -15,628 +4.9% -23,568 +3.7% Gross Operating Income 12,451 +1.3% 15,990 +4.3% Cost of risk -1,973 +6.6% -3,452 +8.2% Net income Group share 7,074 -0.2% 8,754 +1.3% Cost/income ratio 55.7% +0.9 pp 59.6% -0.1 pp HIGH FULL-YEAR RESULTS High full-year results and profitability (>€7bn for Crédit Agricole S.A., return on tangible equity of 13.5%), driven by record annual revenues that were able to absorb the additional corporate income tax charge (Crédit Agricole Group: €280m, Crédit Agricole S.A €147m) (>€7bn for Crédit Agricole S.A., return on tangible equity of 13.5%), driven by (Crédit Agricole Group: €280m, Crédit Agricole S.A €147m) Quarterly results impacted by the effect of the first consolidation of Banco BPM and high-level quarterly revenues driven by good performances by all business lines and marked by the upturn of Retail Banking in France driven by good performances by all business lines and marked by the upturn of Retail Banking in France Stable cost of risk (Crédit Agricole Group: 28 basis points on outstandings, Crédit Agricole S.A.: 35 basis points on outstandings) PROPOSED 2025 DIVIDEND INCREASE TO €1.13 PER SHARE (+3% VS. 2024) STRONG GROWTH MOMENTUM IN ALL BUSINESS LINES IN 2025 High loan production : in France, upturn in home loans (+21%) and good momentum in corporate loans; strong international activity; high-level and balanced production between personal finance and mobility : in France, upturn in home loans (+21%) and good momentum in corporate loans; strong international activity; high-level and balanced production between personal finance and mobility Record annual revenues and net inflows in Insurance , driven by all activities, and a high level of net inflows in Asset Management , driven by all activities, and a Record Corporate and Investment Banking revenues for this qua...

George Efstathopoulos sold a chunk of his gold holdings days before the precious metal’s biggest slide in four decades . Now he’s getting ready to buy again. “If we see another 5%, 7% correction, I’m buying up,” Efstathopoulos, a portfolio manager at Fidelity International , said in an interview Tuesday. “A lot of the froth has been taken out, and the structural sort of medium-term themes are very much in place” for gold to continue rallying. Read More: Gold Holds Gains After Historic Retreat Lures Back Dip Buyers Efstathopoulos cut his gold exposure to about 3% from around 5% early last week, booking profits before bullion plunged Friday on concerns Kevin Warsh — seen by some as a policy hawk — would be nominated as Federal Reserve Chairman. The money manager sold even as the metal rose to a record on haven demand triggered by concerns about currency debasement, the Fed’s independence and geopolitical tensions. Chinese speculators ’ buying had also added froth to the rally. Efstathopoulos is one of the first prominent global fund managers to express optimism about gold’s outlook after the recent rout, a view shared by some banks including Deutsche Bank AG, which is standing by its forecast for bullion to rally to $6,000 an ounce. The precious metal has rebounded for two consecutive days, thanks to dip buyers that have emerged after the historic price collapse. Bullion climbed as much as 2.8% to above $5,080 an ounce on Wednesday, after jumping more than 6% in the previous session. It hit an all-time high of $5,595.47 an ounce on Jan. 29. Efstathopoulos, who helps oversee about $3 billion in income and growth strategies at Fidelity, said the factors that have driven gold to record highs remain intact. “Inflation continues to be sticky,” he said, adding that dollar weakness is an additional driver. Meanwhile, massive buying from central banks and investors’ diversification away from US assets are also favorable trends. A survey published by the Official Monetary and ...

Hong Kong’s CK Hutchison ( CKHUY ) said Wednesday that its Panama Ports Company unit has launched international arbitration against Panama after the country’s top court revoked its licenses to operate two Panama Canal ports, in a dispute that could take years to resolve. Panama's Supreme Court last week ruled the contracts violated Panama's constitution by giving the company exclusive privileges and tax exemptions. The ruling and the decision to pursue arbitration raise questions about the future ownership of the two ports, which CK Hutchison has managed for nearly 30 years, as well as the company’s planned $23 billion sale of its port assets. Source: Press Release More on CK Hutchison Holdings Limited Panama's top court strikes down CK Hutchison port contracts in blow to China China now demands controlling stake for Cosco in Panama ports deal - report Seeking Alpha’s Quant Rating on CK Hutchison Holdings Limited Historical earnings data for CK Hutchison Holdings Limited Dividend scorecard for CK Hutchison Holdings Limited

Southeast Asia telecom tower operator EdgePoint Infrastructure has secured a $475 million syndicated loan from a mix of institutional investors and traditional banks, according to people familiar with the matter. Allianz Global Investors , NEC Capital and Affin Bank were among the lenders that joined the syndicated facility, which closed last month, the people said, who asked not to be identified discussing private matters. The financing was initially marketed as a private credit deal before being underwritten by a consortium of banks at a later stage due to tight pricing. Despite pricing concerns, some non-bank lenders opted to participate in the end to diversify their portfolios, the people said. Representatives for EdgePoint and AllianzGI declined to comment, while Affin Bank and NEC Capital didn’t immediately respond to requests for comment. The deal underscores how private credit funds and traditional lenders are increasingly operating side-by-side in financing deals in Asia Pacific — a region flush with bank liquidity. At the end of last year, Indonesian energy and chemicals firm PT Chandra Asri Pacific Tbk secured loans from both financial institutions and private debt players to fund its purchase of Esso-branded service stations in Singapore from Exxon Mobil Corp. Private credit firms often face pricing pressures from banks, which typically offer loans 200 to 400 basis points cheaper, according to an industry report . Even so, the region’s private credit market is projected to grow to $92 billion in 2027 from $59 billion in 2024. EdgePoint, a portfolio company of US-based infrastructure firm DigitalBridge Group Inc., has a presence in Malaysia, Indonesia and the Philippines, according to its website . It’s also backed by sovereign wealth fund Abu Dhabi Investment Authority and International Finance Corp. Private Credit Grows in Singapore as Australia’s IFM Joins List SeaTown Boosts India Presence With First Private Credit Hire BlackRock’s HPS Makes Its First...

This interactive model has a limit on the number of drivers that can be modified in a single scenario. When the limit is reached those drivers not yet modified become disabled for modification. Your options are: Create new scenarios to try different combinations of driver modifications Reset one of your driver modifications in this scenario in order to modify another driver

South Korea’s top diplomat met with Secretary of State Marco Rubio as the country scrambles to avoid a threatened US tariff hike to 25% while lawmakers in Seoul prepare to review a special bill required to implement funding pledged as part of last year’s trade agreement. Cho Hyun held talks with Rubio in Washington on Tuesday on the sidelines of a ministerial meeting on critical minerals, South Korea’s Foreign Ministry said. “Minister Cho explained our domestic efforts to implement the tariff agreement between South Korea and the US, as well as our investment commitments to the US,” it said in a readout. The meeting took place after President Donald Trump said last week he would raise the levy on goods imported from the Asian nation from the current 15% level to 25%, citing what he said was the failure of the country’s legislature to codify the trade deal the two nations reached last year. Read more: US Trade Spat With South Korea Driven by Tech Laws, Gridlock Before departing for Washington, Cho said he will seek US understanding on South Korea’s legislative process. Cho’s visit follows Industry Minister Kim Jung-kwan ’s talks with Secretary of Commerce Howard Lutnick in the US last week, where Kim said he has clarified that Seoul has no intention of delaying or failing to implement the trade deal with Washington. In Seoul, Finance Minister Koo Yun-cheol went to parliament to seek cooperation for a swift review and passage of the so-called Special Law on Strategic Investment with the US, which is intended to underpin South Korea’s pledges of investing $350 billion in the US. Last year the two nations had spent months working on a trade agreement that brought down threatened US tariff rates in exchange for investment promises, but Trump’s latest move points to the risks the US’s trading partners still face. It’s unclear if or when the US would move to raise the tariff as threatened , but Seoul officials have said that the US appears to be having internal discussions...

Press release 4 February 2026 - N° 03 January 2026 P&C Reinsurance Renewals Selective growth in a competitive pricing environment In a competitive pricing environment, SCOR grows its P&C portfolio selectively, seizing profitable opportunities while maintaining a strong underwriting discipline. During the January 2026 P&C renewals, SCOR delivers EGPI1 growth of 4.7% for traditional reinsurance and 80.5% for Alternative Solutions. With its diversified portfolio mix and retrocession buying, SCOR achieves an expected increase in its underwriting ratio of 2.0 percentage points. Supported by its Tier 1 franchise and active portfolio steering, SCOR achieves targeted growth: EGPI 1 increase of 7.4% for P&C Lines, with growth driven by a flight-to-quality, by markets in APAC and North America, and by core clients; Disciplined underwriting results in active portfolio steering and margin protection in Specialty Lines, which grew by 0.3% amid pressure on insurance and reinsurance pricing; Continued momentum in Alternative Solutions with EGPI 1 growth of 80.5%, driven by capital relief transactions. Jean-Paul Conoscente, CEO of P&C at SCOR, comments: “In a more competitive environment, we are satisfied with the outcome of the 1.1 renewals, which combine growth with an adequate level of profitability. SCOR achieved targeted growth of 4.7% for its traditional reinsurance, leveraging its franchise to grow with core clients under broadly stable terms and conditions, including attachment points. The increase in the net underwriting ratio is estimated at 2.0 percentage points, supported by our retrocession buying. I also want to highlight the continued momentum in Alternative Solutions, where we delivered another strong renewal season driven mostly by our core appetite for capital relief transactions. Looking ahead, we believe SCOR can continue to play on its strengths to capture profitable opportunities.” January 2026 P&C Reinsurance Renewals Demand for reinsurance coverage remains e...

Communiqué de presse 4 février 2026 - N° 03 Renouvellements P&C de janvier 2026 Croissance sélective dans un environnement tarifaire concurrentiel Dans un environnement tarifaire concurrentiel, SCOR développe son portefeuille P&C de manière sélective, saisissant des opportunités rentables tout en maintenant une politique de souscription disciplinée. Lors des renouvellements de janvier 2026, SCOR enregistre une croissance de l’EGPI1 de 4,7 % pour la réassurance traditionnelle et de 80,5 % en « Alternative Solutions ». Grâce à la composition diversifiée de son portefeuille et à ses achats de rétrocession, SCOR anticipe une augmentation de son ratio de souscription de 2.0pp. Soutenue par son fonds de commerce de premier plan et par un pilotage dynamique de son portefeuille, SCOR réalise une croissance ciblée : Une augmentation de l’EGPI 1 de 7,4 % pour les lignes P&C, la croissance étant tirée par le « flight-to-quality » opéré par ses clients, par les marchés d’Asie-Pacifique et d’Amérique du Nord, ainsi que par ses cédantes multilignes ; Une discipline de souscription conduisant à un pilotage dynamique du portefeuille afin de protéger ses marges dans les lignes « Specialty ». Ces lignes enregistrent une croissance de 0,3 % dans un contexte de pression sur les tarifs d’assurance et de réassurance ; Une dynamique maintenue en « Alternative Solutions » enregistrant une croissance de l’EGPI 1 de 80,5 %, tirée par les transactions d'optimisation des besoins en capital. Jean-Paul Conoscente, Directeur général de l’activité P&C de SCOR, déclare : « Dans un environnement plus concurrentiel, nous sommes satisfaits du résultat des renouvellements de janvier, qui conjuguent croissance et niveau approprié de rentabilité. SCOR a réalisé une croissance ciblée de 4,7 % en réassurance traditionnelle en s’appuyant sur son fonds de commerce pour se développer auprès de ses cédantes multilignes, et en maintenant des termes et conditions globalement inchangés, y compris sur les points d...

There's a scratchiness, perhaps a suspicion, about the new levels of scrutiny. In our final conversation for the documentary, I asked Farage what the downside of the party's recent success had been. His answer seemed both candid and revealing. "The worst thing is you wake up in the morning. A local councillor from somewhere in the country has done something or said something and guess what? You're the one that's responsible," he told me. "I'm more than happy to answer for myself and what I get and what get wrong. But that's the trouble with politics. The trouble with political leadership is you actually become responsible for everything."

格隆汇2月4日｜国盛证券研报指出，豪恩汽电是智能驾驶感知龙头，机器人开启新增长曲线。公司深耕汽车智能驾驶感知领域十余载，覆盖日产、大众、吉利等国内外知名车企，主要感知产品包括车载摄像系统、车载视频行驶记录系统、超声波雷达，2022年收入占比分别为55%/20%/25%。公司同步布局机器人领域，形成“感知+决策”一体化布局，搭载JetsonThor的域端控制器预计后续推出，奠定公司在机器人决策领域的竞争优势，开启新增长曲线。公司智驾业务基本盘夯实，机器人赛道布局开启新增长曲线。考虑到公司持续拓展新产品，单车价值量提升，机器人布局打开成长边界，首次覆盖，给予“买入”评级。

The bull shark has been linked to several recent attacks in Australia. At the end of January, the country saw four shark attacks in just 48 hours, one resulting in the death of a 12-year-old boy. Three of the attacks were within a nine mile (15km) stretch of each other on the east coast.

文章提及标的 同花顺 -- 据同花顺（300033）iFinD数据，沪深京三市成交额超2万亿元，较上日此时缩量338亿元，预计全天成交金额约2.5万亿元。截至目前，沪市成交额8485亿元，深市成交额11341亿元，北证50成交额174亿元。

格隆汇2月4日｜TCL中环直线拉升涨停，晶科能源涨停，晶盛机电拉升逼近20CM涨停。消息面上，据报，上周马斯克团队对包括TCL中环、晶科能源、晶盛机电等中国光伏企业进行了调研。

The health board said it would not comment on the specific detail of the WalesOnline report in which the review was leaked, but in a statement to BBC Wales said it was "satisfied that we have dealt with the very challenging [and in this instance] historical allegations robustly, fairly, equitably and with compassion".

此次上海之行，裴淳华逛豫园、游外滩，而最重要的行程之一，便是参与其新作《非穷尽列举》的映后交流。 要说哪位国际影星对中国文化抱有热忱，裴淳华（Rosamund Pike）一定是其中的代表人物。 2015年，这位凭借《消失的爱人》名声大噪的英国女演员，在为影片来华宣传时，正式启用中文名裴淳华。她曾分享名字的由来：“裴”与她的姓氏Pike音近；“淳”寓意坦率、简单与诚实；“华”既代表中国，又取“花”的谐音，呼应其本名Rosamund，意为世间的玫瑰。在她看来，相较于纯粹的音译，这个中文名是对中国观众的尊重。 今年1月末，英国首相斯塔默到访上海创新创意设计研究院，裴淳华同框亮相，再度引发关注。与中国学生交流时，她又一次表达了对中国文化的喜爱，认为“中文是未来的语言”。她分享了生活中的偶遇，走在伦敦街头，若有人喊“裴淳华”，她会下意识回头，“这种感觉很美好。中国观众喜欢这个名字，也理解它的含义，这让我感到自豪。” 裴淳华的家人同样热爱中国文化。伴侣尤儒笔（Robie Uniacke）是“中国通”，大儿子尤子君曾获“汉语桥”世界中学生中文比赛全球总冠军。她本人也多次来华旅游，并担任奈飞剧集《三体》的制片人。“刘慈欣的《三体》三部曲是我看过最优秀的科幻作品之一。我一直希望将中国的精彩故事介绍给欧美乃至全球观众，《三体》是这段旅程的开始。”她说。 此次上海之行，她逛豫园、游外滩，而最重要的行程之一，便是参与其新作《非穷尽列举》（Inter alia）的映后交流。 《非穷尽列举》为编剧苏茜·米勒和导演贾斯汀·马丁继《初步举证》后推出的新作，这也是裴淳华时隔14年重返戏剧舞台担纲领衔主演。此次在西岸大剧院举办的放映，为该剧的NT live（英国国家剧院现场）高清影像版。 2月2日，西岸大剧院主剧场坐满了从各地赶来的观众。映后环节，裴淳华一身简约黑色西服登场，从容优雅，引发全场欢呼。面对主持人周轶君、学者毛尖及现场观众的提问，她耐心倾听，给出详尽而真诚的回答。 对谈从原定的40分钟延长至70分钟。活动结束时已过晚上10点半，裴淳华并未匆匆离场，而是径直走向观众席，接过粉丝递来的海报、照片与票根，一一签名。 从邦女郎到“消失的爱人” 相较于生活中的风趣亲和，银幕上的裴淳华多变、迷人而危险。 从牛津大学毕业后，她在英国国立青年剧团出演《罗密欧与朱丽叶》时被发掘。2002年，她在《007之择...

jittawit.21/iStock via Getty Images I believe Pharming Group ( PHAR ) has recently passed a critical inflection point and moved from being a highly speculative play into a fundamentally attractive investment. Historically, Pharming has been viewed by the market as a one-product story based upon the success of its hereditary angioedema franchise. Recent updates indicate a major shift away from the historical view of the company's product line. As Pharming enters 2026 with a cash-generating business model, I think it will be able to endure macroeconomic volatility much better than many of its peers that are still in a pre-revenue state. Latest Financials The biggest takeaway from Pharming's last financial updates is the clear trend toward a self-sustaining business model. Pharming reported a preliminary total revenue of $376M in the fiscal year 2025. The preliminary total revenue is important because it shows a 27% year-over-year increase and clearly surpassed the top end of the company's revised revenue guidance of $365-$375M. For many companies in the sector, missing a forecast is common, so beating expectations (in this case) indicates that the company understands the market dynamics and has been conservative with their forecasts. Breaking down the third quarter of 2025 further, the growth became much clearer. Third-quarter revenues were $97.3M, representing a 30% year-over-year increase in revenues over the same time frame as the prior year. Both commercial products had a very successful third quarter. RUCONEST generated $82.2M during the third quarter, representing a 29% year-over-year increase. Joenja generated $15.1M, which represents a very strong 35% year-over-year increase. A stronger-than-expected performance by Joenja is especially exciting because it supports the U.S. commercial launch strategy and provides evidence that the patient identification efforts are beginning to pay off. pharming.com (Investor Presentation) Operating profit jumped 285% in the th...

騰訊控股(00700)出現大手賣出1.35萬股，成交價$562.0，涉資758.7萬 AASTOCKS.com

騰訊控股(00700)出現大手賣出5.21萬股，成交價$562.5，涉資2.931千萬 AASTOCKS.com

騰訊控股(00700)出現大手賣出3萬股，成交價$562.0，涉資1.686千萬 AASTOCKS.com

騰訊控股(00700)出現大手買入1萬股，成交價$561.0，涉資561萬 AASTOCKS.com

宁德时代成交额达100亿元 2026-02-04 13:54:36 来源： 同花顺7x24快讯 分享 文章提及标的 宁德时代 -- 宁德时代（300750）成交额达100亿元，现涨3.10%。

Equinor press release ( EQNR ): Q4 Non-GAAP EPS of $0.81 beats by $0.14 . Revenue of $25.35B (-8.3% Y/Y) beats by $4.04B . Equinor had high production in the fourth quarter, with a total equity production of 2,198 mboe per day, up 6% from 2,072 mboe per day in the same quarter last year. Equinor realised a European gas price of USD 10.6 per mmbtu and realised liquids prices were USD 58.6 per bbl in the fourth quarter of 2025. High production generated cash flows provided by operating activities, before taxes paid and working capital items, of USD 9.55 billion for the fourth quarter. Organic capital expenditure* was USD 3.29 billion for the quarter and USD 13.1 billion for the full year. The net debt to capital employed adjusted ratio* was 17.8% at the end of the fourth quarter, compared to 12.2% at the end of the third quarter of 2025. Proposed increase of fourth quarter cash dividend to USD 0.39 per share. Announced share buy-back of up to USD 1.5 billion for 2026. “In 2026, we expect around 3 percent production growth, up from record levels in 2025. We are taking firm actions to strengthen free cash flow, remain robust towards lower prices and maintain competitive capital distribution.” Outlook: Organic capital expenditures are estimated at around USD 13 billion for 20265 . Oil & gas production for 2026 is estimated to grow around 3% compared to 2025 level. Equinor’s ambition is to keep the unit of production cost in the top quartile of its peer group. Scheduled maintenance activity is estimated to reduce equity production by around 35 mboe per day for the full year of 2026. More on Equinor Equinor: A Strategic European Energy Buy With Margin Of Safety Equinor: Share Price Pullback Makes It A High Dividend-Yielding Investment Opportunity Equinor: A 7% Income Opportunity For An Oil Recovery Equinor Q4 2025 Earnings Preview Europe's oil majors prepare to cut billions in shareholder payouts - FT

小米集團－Ｗ(01810)出現大手買入29.4萬股，成交價$34.0，涉資999.6萬 AASTOCKS.com

Germany's Uniper downplays increasing reliance on US LNG, stresses diversification Reuters